James Michael C's Form 4 filing
Guided Therapeutics Inc (GTHP) · filed Sep 5, 2025
- Accession no.
- 0001477932-25-006513
- Filed
- Sep 5, 2025, 11:50 AM ET
- Trade date
- Aug 29, 2025
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $5.00K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| James Michael CCIK 0001365831 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Common Stock | PPurchaseAcquired | +27,778 | $0.18 | +$5,000.04 | 553,495 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Common Stock | PPurchaseAcquired | +27,778 | – | – | 52,778 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.